Merck expands Mass. reach with Torque cancer collaboration
Cambridge biotech Torque has become the latest local startup to team up with New Jersey drug giant Merck& Co., announcing a collaboration this week to explore whether Merck's blockbuster drug Keytruda could boost Torque's lead immuno-oncology treatment.
Under the partnership announced Wednesday, Torque and Merck (NYSE: MRK) will test Torque’s lead T-cell therapy's ability fight multiple types of cancer tumors when paired with Keytruda or used independently. The companies are planning to launch…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Allison DeAngelis Source Type: news
More News: Biotechnology | Cancer | Cancer & Oncology | Health Management | Merck | Partnerships | Pharmaceuticals